Delivery Order SPE2DB20D2104-SPE2DB25FMXDE
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Troop Support Medical awarded a $1,530.93 delivery order to Amerisourcebergen Drug Corporation for the product "MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 5-6, 2023. This firm fixed price order was placed under an indefinite-delivery/indefinite-quantity contract vehicle, though details of the underlying contract were not...
- This federal contract award, valued at $1,557.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S pharmaceutical products. The contract, which runs until January 8, 2025, is a firm fixed price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,217.50 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S medication. The contract has an ultimate completion date of May 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a $3,959.78 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a medical product, with a period of performance through November 8, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product, with a ceiling value of $1,607.13 and a period of performance ending on July 7, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded on October 30, 2024, is a Firm Fixed Price Delivery Order valued at $1,180.74 with a completion date of October 31, 2024. The contract covers the procurement of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product, with no set-aside designation. AmerisourceBergen also holds a significant...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB23FN2G5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.90 delivery order contract is for the medical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, with a completion date of May 1, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.79 firm fixed-price delivery order contract, with a completion date of January 8, 2025, is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,542.20, is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract has a completion date of February 25, 2025 and is a firm fixed-price delivery order. There is no set-aside designation indicated for this award. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a $3,891.46 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is to provide MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, which are likely specialty pharmaceutical products, to support military healthcare programs. The award does not have a set-aside designation, indicating open competition....